These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32528131)
21. FEN1 participates in repair of the 5'-phosphotyrosyl terminus of DNA single-strand breaks. Kametani Y; Takahata C; Narita T; Tanaka K; Iwai S; Kuraoka I Carcinogenesis; 2016 Jan; 37(1):56-62. PubMed ID: 26581212 [TBL] [Abstract][Full Text] [Related]
22. Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes. Hoa NN; Shimizu T; Zhou ZW; Wang ZQ; Deshpande RA; Paull TT; Akter S; Tsuda M; Furuta R; Tsutsui K; Takeda S; Sasanuma H Mol Cell; 2016 Nov; 64(3):580-592. PubMed ID: 27814490 [TBL] [Abstract][Full Text] [Related]
23. Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway. Park JM; Zhang H; Nie L; Wang C; Huang M; Feng X; Tang M; Chen Z; Xiong Y; Lee N; Li S; Yin L; Hart T; Chen J Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047518 [TBL] [Abstract][Full Text] [Related]
24. Atp-bound topoisomerase ii as a target for antitumor drugs. Wang H; Mao Y; Zhou N; Hu T; Hsieh TS; Liu LF J Biol Chem; 2001 May; 276(19):15990-5. PubMed ID: 11278845 [TBL] [Abstract][Full Text] [Related]
25. SUMO-Targeted DNA Translocase Rrp2 Protects the Genome from Top2-Induced DNA Damage. Wei Y; Diao LX; Lu S; Wang HT; Suo F; Dong MQ; Du LL Mol Cell; 2017 Jun; 66(5):581-596.e6. PubMed ID: 28552615 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors. Macieja A; Kopa P; Galita G; Pastwa E; Majsterek I; Poplawski T Mol Biol Rep; 2019 Aug; 46(4):3625-3636. PubMed ID: 31020489 [TBL] [Abstract][Full Text] [Related]
27. Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide. Tammaro M; Barr P; Ricci B; Yan H PLoS One; 2013; 8(11):e79202. PubMed ID: 24244448 [TBL] [Abstract][Full Text] [Related]
28. ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms. Shu J; Wang X; Yang X; Zhao G Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267 [TBL] [Abstract][Full Text] [Related]
29. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II. Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000 [TBL] [Abstract][Full Text] [Related]
30. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms. Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820 [TBL] [Abstract][Full Text] [Related]
31. Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons. Huelsenbeck SC; Schorr A; Roos WP; Huelsenbeck J; Henninger C; Kaina B; Fritz G J Biol Chem; 2012 Nov; 287(46):38590-9. PubMed ID: 23012366 [TBL] [Abstract][Full Text] [Related]
32. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility. Atkin ND; Raimer HM; Wang YH Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754 [TBL] [Abstract][Full Text] [Related]
33. Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition. Yi JM; Zhang XF; Huan XJ; Song SS; Wang W; Tian QT; Sun YM; Chen Y; Ding J; Wang YQ; Yang CH; Miao ZH Oncotarget; 2015 Apr; 6(11):8960-73. PubMed ID: 25840421 [TBL] [Abstract][Full Text] [Related]
34. A DNA repair player, ring finger protein 43, relieves etoposide-induced topoisomerase II poisoning. Lerksuthirat T; Wikiniyadhanee R; Stitchantrakul W; Chitphuk S; Stansook N; Pipatpanyanugoon N; Jirawatnotai S; Dejsuphong D Genes Cells; 2020 Nov; 25(11):718-729. PubMed ID: 32939879 [TBL] [Abstract][Full Text] [Related]
35. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo. Gómez-Herreros F; Romero-Granados R; Zeng Z; Alvarez-Quilón A; Quintero C; Ju L; Umans L; Vermeire L; Huylebroeck D; Caldecott KW; Cortés-Ledesma F PLoS Genet; 2013; 9(3):e1003226. PubMed ID: 23505375 [TBL] [Abstract][Full Text] [Related]
36. Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer. Wijdeven RH; Pang B; van der Zanden SY; Qiao X; Blomen V; Hoogstraat M; Lips EH; Janssen L; Wessels L; Brummelkamp TR; Neefjes J Cancer Res; 2015 Oct; 75(19):4176-87. PubMed ID: 26260527 [TBL] [Abstract][Full Text] [Related]
37. A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes. Swan RL; Cowell IG; Austin CA Mol Pharmacol; 2021 Jul; 100(1):57-62. PubMed ID: 33941661 [TBL] [Abstract][Full Text] [Related]
38. Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses. Fan JR; Peng AL; Chen HC; Lo SC; Huang TH; Li TK DNA Repair (Amst); 2008 Mar; 7(3):452-63. PubMed ID: 18206427 [TBL] [Abstract][Full Text] [Related]
39. DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac. Wartlick F; Bopp A; Henninger C; Fritz G Biochim Biophys Acta; 2013 Dec; 1833(12):3093-3103. PubMed ID: 23999236 [TBL] [Abstract][Full Text] [Related]
40. Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in Tombline G; Millen JI; Polevoda B; Rapaport M; Baxter B; Van Meter M; Gilbertson M; Madrey J; Piazza GA; Rasmussen L; Wennerberg K; White EL; Nitiss JL; Goldfarb DS Aging (Albany NY); 2017 Jan; 9(1):68-97. PubMed ID: 28077781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]